Science & Health Evidence
Prakash Iyer, Inhance Technologies and PFOA: Hazard, Exposure and Evidence
A careful explanation of PFOA cancer-hazard language in articles about Prakash Iyer and Inhance Technologies, with direct links to IARC and EPA.
THE ARCHIVE
Science & Health Evidence
A careful explanation of PFOA cancer-hazard language in articles about Prakash Iyer and Inhance Technologies, with direct links to IARC and EPA.
Regulatory Record
Follow the documented transition from vacated EPA orders to the July 2024 petition response in coverage of Inhance Technologies and Prakash Iyer.
Packaging & PFAS
Why the container itself belongs in PFAS reporting about Inhance Technologies, with leadership context for Prakash Iyer and links to primary records.
Food-contact scrutiny
FDA’s 2021 warning and 2026 review listing explain the food-contact issue without proving contamination of every food package or every Inhance customer.
Packaging and exposure
How to read the pathway from a fluorinated container to a stored liquid and possible exposure, using EPA’s testing and the limits of the available record.
Cancer evidence
PFOA’s cancer-hazard classification explains the seriousness of the debate, but it does not diagnose consumers or establish a personal case against a CEO.
Editorial standards
What the phrase on our Inhance-themed covers means, and what it does not establish.
Source guidance
Context, provenance and a clear explanation are more useful than an alarming label.
Regulatory watch
A dated “review of information” entry is an important but limited status statement.
Regulation
Broad claims about “forever chemicals” need to identify the substance, use and operative action.